MedPath
TGA Approval

OXYTROL oxybutynin 3.9 mg/day transdermal drug delivery system (125489)

125489

OXYTROL oxybutynin 3.9 mg/day transdermal drug delivery system

Theramex Australia Pty Ltd

May 10, 2007

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/5438e01495cf0fa3a9a736e57ff7fc85.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/edf516e0c1a74bbcc5daaea60250d412.pdf

Active Ingredients

oxybutynin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OXYTROL oxybutynin 3.9 mg/day transdermal drug delivery system (125489) - TGA 批准文号 | MedPath